ALKS
Alkermes Plc
NASDAQ: ALKS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$45.25
+2.10% today
Updated 2026-10-28
Market cap
$6.92B
P/E ratio
108.47
P/S ratio
4.15x
EPS (TTM)
$0.38
Dividend yield
—
52W range
$27 – $56
Volume
2.0M
Alkermes Plc (ALKS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$45.25
12-Month target
$28.21
2030 Target
—
Intrinsic (DCF)
$75.72
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.1B | $1.7B | $1.6B | $1.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 3.97%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.